Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Latest Information Update: 02 Sep 2024
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms Gist-Ten
- 31 Aug 2023 Planned End Date changed from 1 Oct 2024 to 1 Jan 2027.
- 31 Aug 2023 Planned primary completion date changed from 1 Apr 2022 to 1 Jan 2025.
- 14 Mar 2022 Status changed from not yet recruiting to recruiting.